医药即时零售争夺战：美团领跑，京东加速破局

Core Insights - The competition in the instant retail sector has intensified with Meituan launching its instant retail brand "Meituan Flash Purchase" and JD.com introducing "Self-operated Seconds Delivery" [1] - Instant retail emphasizes "30-minute delivery" and is based on consumer location, covering various product categories including food, clothing, cosmetics, 3C digital products, and pharmaceuticals [1] - The pharmaceutical sector is seeing instant retail channels becoming a core growth driver, with a projected sales scale of 48.7 billion yuan in 2024, representing a 31.3% increase from 2023 [1] Group 1: Market Dynamics - Meituan, JD.com, Ele.me, and Douyin have all entered the instant retail space, with Meituan holding a dominant market share of over 70% in the pharmaceutical instant retail sector [1][2] - The overall sales scale of China's pharmaceutical retail terminals is expected to reach 574 billion yuan in 2024, with online pharmacy sales projected to grow by 14.4% [2] Group 2: Company Performance - Meituan's revenue for 2024 is projected to reach 337.6 billion yuan, with a net profit increase of 88.2% [3] - JD Health has launched its "Seconds Delivery" service, achieving a revenue of 58.2 billion yuan in 2024, with 48.8 billion yuan coming from pharmaceutical and health products [5] Group 3: Consumer Trends - The number of active users in the instant retail sector reached approximately 580 million in 2023, marking a 34.88% year-on-year increase [5] - The penetration rate of instant retail is higher in first- and second-tier cities, but there is rapid growth in third- and fourth-tier cities [6] Group 4: Competitive Landscape - The competition among platforms focuses on merchant numbers, service quality, and user habit formation [8] - Ele.me has expanded its pharmacy network to over 15,000 locations, with a 50% increase in nighttime transaction volume [7] - Douyin has also entered the instant retail market, testing "Seconds Delivery" services in Shenzhen [7]